Gene · 197259
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Prospects for Necroptosis in Inflammatory Diseases: A Bibliometric Analysis. | Curr Med Chem | 2026 | 39844404 | PubTator, text mining | PubMed |
| Resveratrol Targets Glycolytic Enzymes HK II and PKM2 to Promote Concurrent Apoptotic and Necrotic Cell Death in Malignant Melanoma. | Curr Issues Mol Biol | 2025 | 41614770 | PubTator, text mining | PubMed |
| Targeting TNFR1-driven necroptosis in breast cancer. | EXCLI J | 2025 | 41584509 | PubTator, text mining | PubMed |
| Lactate attenuates PANoptosis and enhances ZBP-1 lactylation in macrophages in acute lung injury. | Front Immunol | 2025 | 41479902 | PubTator, text mining | PubMed |
| Decoding necrosome assembly: harmonizing signal amplification and attenuation through optimal RIP3 stoichiometry. | Nat Commun | 2025 | 41436733 | Swiss-Prot, curated | PubMed |
| Necroptotic signaling orchestrates glioblastoma malignancy and potentiates temozolomide response. | Cell Death Dis | 2025 | 41429922 | PubTator, text mining | PubMed |
| Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression. | Nat Commun | 2025 | 41413044 | PubTator, text mining | PubMed |
| MLKL/retromer axis controls PD-L1 recycling to compromise antitumor immunity during VCP inhibition-induced necroptosis. | Proc Natl Acad Sci U S A | 2025 | 41400993 | PubTator, text mining | PubMed |
| DLL4+ neutrophils promote Notch1-mediated endothelial PANoptosis to exacerbate acute lung injury in sepsis. | J Clin Invest | 2025 | 41392977 | PubTator, text mining | PubMed |
| Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD. | bioRxiv | 2025 | 41383755 | PubTator, text mining | PubMed |
Changes in Expression Profiles of Caspase-8 and Mixed Lineage Kinase Domain-Like Protein/Receptor-Interacting Protein Kinase 3 Mediated by Inflammation in Cerebral Arteriovenous Malformations Associated With Clinical Condition on Admission. | J Am Heart Assoc | 2025 | 41378489 | PubTator, text mining | PubMed |
| Exploring the role of PANoptosis in idiopathic pulmonary fibrosis based on scRNA-seq and bulk-seq. | Clin Exp Med | 2025 | 41369928 | PubTator, text mining | PubMed |
| Identification of an IRF-ZBP1-caspase-8-NINJ1 axis in driving PANoptosis and pathology during alcohol-associated liver disease. | Proc Natl Acad Sci U S A | 2025 | 41359840 | PubTator, text mining | PubMed |
| GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions. | Cell Death Discov | 2025 | 41354733 | PubTator, text mining | PubMed |
| Proteolysis targeting chimera degraders target pseudokinases to treat metabolic dysfunction-associated steatohepatitis and fibrosis: Mechanisms and therapeutic insights. | Pharmacol Res | 2025 | 41344548 | PubTator, text mining | PubMed |
| Si-Miao-Yong-An decoction suppresses necroptosis by regulating the p53 pathway in myocardial ischemia/reperfusion injury. | Sci Rep | 2025 | 41339643 | PubTator, text mining | PubMed |
| Trigger Points of Necroptosis (RIPK1, RIPK3, and MLKL)-Promising Horizon or Blind Alley in Therapy of Colorectal Cancer? | Int J Mol Sci | 2025 | 41303584 | PubTator, text mining | PubMed |
| The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics. | Int J Mol Sci | 2025 | 41303516 | PubTator, text mining | PubMed |
| FLASH-AWAY: Intrabody-Directed Targeting of Optogenetic Tools for Protein Degradation. | ACS Synth Biol | 2025 | 41277159 | PubTator, text mining | PubMed |
| Abstracts of the Annual Conference of the German Society for Biological Radiation Research (DeGBS) : Munich, Germany. 29 September-1 October 2025. | Radiat Oncol | 2025 | 41254773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/197259/papers?page=14